Skip to main content
. 2024 May 25;13(7):1515–1530. doi: 10.1007/s40121-024-00980-9

Table 2.

Parameter estimates of the final population PK model

Model parameter Description Estimate RSE, %a IIV (CV%) Shrinkage, %
CL/F (l/h) Apparent systemic clearance 3.10 2.89 0.096 (31.7) 31.9
WT on CL/F Weight exponent on CL/F 0.494 0.0237
V2/F (L) Apparent volume of distribution of the central compartment 11.7 2.47 0.154 (40.8) 54.6
WT on V2/F Weight exponent on V2/F 1.01 0.0247
KA (h–1) Absorption rate constant 0.237 3.48 0.192 (45.9) 47.9
ALAG1 (h), healthy Absorption lag time 0.232 4.68 0.136 (38.2) 54.5
Chronic HBV infection on ALAG1 Proportional shift for chronic HBV infection on ALAG1 – 0.466 8.40
Q3/F (l/h) Apparent intercompartmental clearance between central and shallow peripheral compartments 0.107 2.91 0.233 (51.2) 54.1
V3/F (L), healthy Apparent volume of distribution of the shallow peripheral compartment 33.2 1.98 0.448 (75.2) 41.8
Chronic HBV infection on V3/F Proportional shift for chronic HBV infection on V3/F – 0.337 2.56
Q4/F (l/h) Apparent intercompartmental clearance between central and deep peripheral compartments 0.0428 2.69 1.140 (146.0) 25.8
V4/F (L) Apparent volume of distribution of the deep peripheral compartment 63.7 2.25 1.590 (198.0) 15.4
RV (CV%) CCV residual error 0.0449 (21.2) 1.59 0.0986

CL/F (l/h) = 3.10 · (WT/73)^0.494; V2/F (L) = 11.7 · (WT/73)^1.01; ALAG1 (h) = 0.232 (healthy participants); ALAG1 (h) = 0.232 * (1–0.466) (participants with chronic HBV infection); V3/F (l/h) = 33.2 (healthy participants); V3/F (l/h) = 33.2 * (1–0.337) (participants with chronic HBV infection)

ALAG1 absorption lag time, CCV constant coefficient of variation, CL/F apparent clearance following extravascular administration, CV coefficient of variation, HBV hepatitis B virus, IIV interindividual variability, KA first-order absorption rate constant, Q3/F apparent intercompartmental clearance between central and shallow peripheral compartments following extravascular administration, Q4/F apparent intercompartmental clearance between central and deep peripheral compartments following extravascular administration, RSE relative standard error, RV residual variation, V2/F apparent central volume of distribution following extravascular administration, V3/F apparent volume of distribution of the shallow peripheral compartments following extravascular administration, V4/F apparent volume of distribution of the deep peripheral compartments following extravascular administration, WT body weight

aReported RSE% are for the log-transformed parameter values